At Investor Conferences

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Organisation › Details

Cytovant Sciences HK Ltd.

Cytovant Sciences HK Limited, owner of Cytovant Sciences Co., Ltd and affiliate of Roivant Asia Cell therapy Holdings Ltd, is a clinical-stage biopharmaceutical company focused on developing innovative cellular therapeutics in Asia. Roivant/Cytovant's mission is to become Asia's premier cell therapy company by discovering, developing, and commercializing new medicines that are uniquely suited to Asian patients. *

 

Period Start 2020-10-19 existent
  Group Roivant (Group)
Products Industry contract manufacturing (biologicals)
  Industry 2 cancer immunotherapy (immuno-oncology, I-O)
     
Region Region Hong Kong
  Country China
  City n. a. Hong Kong
    Address record changed: 2020-10-26
     
Basic data Employees n. a.
     
    * Document for »About Section«: Medigene AG. (10/19/20). "Press Release: Medigene and Cytovant Enter into Service Agreement for DC Vaccine Manufacturing Process Development". Planegg-Martinsried.
     
   
Record changed: 2023-07-10

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Roivant (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top